|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
66,921,000 |
Market
Cap: |
2.96(B) |
Last
Volume: |
1,212,774 |
Avg
Vol: |
1,004,919 |
52
Week Range: |
$38.26 - $88.63 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile QuidelOrtho is engaged in the development, manufacturing and marketing of diagnostic testing solutions. Co. provides diagnostic testing solutions under various brand names, including, among others, the following: Quidel®, QuickVue®, QuickVue+®, Sofia®, Triage®, Solana®, Virena®, MicroVue, Lyra®, FreshCells, D3®, FastPoint®, ReadyCells®, Super E-Mix, InflammaDry®, AdenoPlus®, ELVIRA®, ELVIS® and Thyretain®. Co.'s diagnostic testing solutions are separated into its four product categories: rapid immunoassay, cardiometabolic immunoassay, molecular diagnostic solutions and specialized diagnostic solutions.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Brown Thomas D |
Director |
|
2016-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
962 |
45,025 |
|
- |
|
Polan Mary Lake Ph D |
Director |
|
2016-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,294 |
24,585 |
|
- |
|
Brown Thomas D |
Director |
|
2016-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,209 |
30,079 |
|
- |
|
Brown Thomas D |
Director |
|
2016-05-05 |
4/A |
OE |
$0.00 |
$0 |
D/D |
962 |
26,816 |
|
- |
|
Slacik Charles P |
Director |
|
2016-05-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
528 |
528 |
|
- |
|
Widder Kenneth J |
Director |
|
2016-05-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
962 |
1,119 |
|
- |
|
Polan Mary Lake Ph D |
Director |
|
2016-05-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
962 |
23,291 |
|
- |
|
Dammeyer Rodney F |
Director |
|
2016-05-05 |
4 |
GA |
$0.00 |
$0 |
I/I |
962 |
42,769 |
|
- |
|
Dammeyer Rodney F |
Director |
|
2016-05-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
962 |
0 |
|
- |
|
Dammeyer Rodney F |
Director |
|
2016-05-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
962 |
962 |
|
- |
|
Buechler Kenneth F |
Director |
|
2016-05-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,204 |
13,025 |
|
- |
|
Brown Thomas D |
Director |
|
2016-05-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
962 |
26,870 |
|
- |
|
Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
|
2016-03-02 |
4 |
D |
$16.32 |
$26,357 |
D/D |
(1,615) |
59,896 |
|
- |
|
Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
|
2016-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
4,520 |
61,120 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2016-03-02 |
4 |
D |
$16.32 |
$160,997 |
D/D |
(9,865) |
274,011 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2016-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
27,580 |
281,485 |
|
- |
|
Steward Randall J |
Chief Financial Officer |
|
2016-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,887 |
16,684 |
|
- |
|
Tamerius John |
SVP, Strat & Ext Affairs |
|
2016-02-28 |
4 |
D |
$16.51 |
$10,467 |
D/D |
(634) |
28,473 |
|
- |
|
Tamerius John |
SVP, Strat & Ext Affairs |
|
2016-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,791 |
28,582 |
|
- |
|
Steward Randall J |
Chief Financial Officer |
|
2016-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
450 |
14,797 |
|
- |
|
Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
|
2016-02-25 |
4 |
D |
$15.57 |
$2,180 |
D/D |
(140) |
56,991 |
|
- |
|
Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
|
2016-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
337 |
57,131 |
|
- |
|
Tamerius John |
SVP, Strat & Ext Affairs |
|
2016-02-25 |
4 |
D |
$15.57 |
$1,277 |
D/D |
(82) |
27,316 |
|
- |
|
Tamerius John |
SVP, Strat & Ext Affairs |
|
2016-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
225 |
27,398 |
|
- |
|
Steward Randall J |
Chief Financial Officer |
|
2016-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
870 |
14,347 |
|
- |
|
1127 Records found
|
|
Page 29 of 46 |
|
|